INAB READ THE FULL INAB RESEARCH REPORT Following the announcement of its new γδ T cell engager platform INB-600, IN8bio, Inc ...
The GEAR platform aims to enhance the effectiveness of cancer therapies by preventing NK cell neutralization, providing a promising new approach to immuno-oncology. "We are thrilled to expand our ...